COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,681 Articles (22,913 medRxiv, 8,768 bioRxiv)

Most recent first Previous |  Page 2642: Articles 26411-26420  | Next

Mental health service activity during COVID-19 lockdown: South London and Maudsley data on working age community and home treatment team services and mortality from February to mid-May 2020
Stewart, R., Martin, E., Broadbent, M.
10.1101/2020.06.13.20130419 — Posted: 2020-06-16
An Extended Laboratory Validation Study and Comparative Performance Evaluation of the Abbott ID NOW COVID-19 Assay in a Coastal California Tertiary Care Medical Center
Comer, S. W., Fisk, D.
10.1101/2020.06.14.20130518 — Posted: 2020-06-16
Random time transformation analysis of Covid19 2020
Meilijson, I., Alon, N.
10.1101/2020.06.13.20130468 — Posted: 2020-06-16
Utility of Lung Ultrasound in COVID-19: A Systematic Scoping Review
Trauer, M., Matthies, A., Mani, N., McDermott, C. B., Jarman, R.
10.1101/2020.06.15.20130344 — Posted: 2020-06-16
Cohen's kappa statistics as a convenient means to identify accurate SARS-CoV-2 rapid antibody tests
Iseki, H.
10.1101/2020.06.13.20130070 — Posted: 2020-06-16
Quantification of SARS-CoV-2 viral copy number in saliva mouthwash samples using digital droplet PCR
Oberding, L., Hu, J., Berenger, B., Mohon, A. N., Pillai, D. R.
10.1101/2020.06.13.20130237 — Posted: 2020-06-16
A systematic review protocol of the antiviral activity of chloroquine and hydroxychloroquine against COVID-19.
Mensah, K. B., Mensah, A. B. B., Bangalee, V., Oosthuizen, F.
10.1101/2020.06.13.20130245 — Posted: 2020-06-16
Spreading Analysis of COVID-19 Epidemic in Bangladesh by Dynamical Mathematical Modelling
Arifutzzaman, A., Fargana, A., Rakhimov, A. A.
10.1101/2020.06.12.20130047 — Posted: 2020-06-16
Prevalence of IgG antibodies to SARS-CoV-2 in Wuhan -implications for the ability to produce long-lasting protective antibodies against SARS-CoV-2
Liu, T., Wu, S., Tao, H., Zeng, G., Zhou, F., Guo, F., Wang, X.
10.1101/2020.06.13.20130252 — Posted: 2020-06-16 Discussion: Onsite
COVID-19: a crash test for biomedical publishing?
Iourov, I. Y., Zelenova, M. A., Vorsanova, S. G.
10.1101/2020.06.13.20130310 — Posted: 2020-06-16

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).